ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: TH-PO289

Parathyroid Hormone Decrease During Sepsis Predicts Re-Hospitalization in Hemodialysis Patients

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis


  • Kruzel Davila, Etty, Galilee Medical Center, Nahariya, North, Israel
  • Kananeh, Majd, Galilee Medical Center, Nahariya, North, Israel
  • Yakir, Orly, Galilee Medical Center, Nahariya, North, Israel

Hemodialysis patients are at significant risk for infections. Given our clinical observation of decreased Parathyroid hormone (PTH) levels during sepsis among hemodialysis patients suffering from secondary hyperparathyroidism, we aim to characterize PTH levels before and during infection and explore its clinical significance.


A retrospective observational study conducted in the nephrology department at the Galilee Medical Center, Israel, between 2020-2022. Hemodialysis patients suffering from sepsis were included. PTH levels at different time points were analyzed using Wilcoxon signed rank test. Multivariable logistic regression analyses were conducted to identify risk factors for rehospitalization and mortality (median follow-up: 12.3 months, range:1.9-35.5). Model 1 included Age≥65 years, gender, dialysis vintage≥4 years and diabetes. Model 2: Similar to model 1 plus C reactive Protein (CRP), neutrophil/lymphocyte ratio (NLR) and albumin during hospitalization. Model 3: Similar to model 2 plus partial PTH decrease compared to baseline PTH.


72 hemodialysis patients were included in this study. The median duration of hospitalization was 9 days (IQR 7-15). 74% were re-hospitalized after discharge while 50% were re-hospitalized within 1.8 months (IQR 0.5-5.8). Infection was the most common rehospitalization diagnosis. The mortality rate during follow-up period was 17% (median survival time: 7.7 months (IQR 3.7-11.9). As hypothesized, PTH levels significantly decreased during sepsis compared to baseline (p<0.001), with partial decrease of 29% (IQR 8%-49%). In the final model of the multivariable logistic regression analyses, several traditional risk factors were associated with re-hospitalization risk: Age≥65 years: OR 5.3, p=0.034 and dialysis vintage≥4 years: OR 5.5, p=0.045. Interestingly, partial PTH decrease during infection was the most significant risk factor for re-hospitalization (OR 12.6, p=0.013). In the final model of the multivariable logistic regression analyses for mortality, only diabetes had a borderline significance (OR 8.6, p=0.065).


In this hemodialysis cohort a significant decrease in PTH levels during infection had the highest OR for re-hospitalization. Further multicenter, prospective studies are needed to validate and explore this association, mechanism, and clinical implications.